0.8955
price up icon9.21%   0.0755
 
loading
Io Biotech Inc stock is traded at $0.8955, with a volume of 188.88K. It is up +9.21% in the last 24 hours and down -27.78% over the past month. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.82
Open:
$0.8314
24h Volume:
188.88K
Relative Volume:
0.41
Market Cap:
$58.37M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.3484
EPS:
-2.57
Net Cash Flow:
$-72.06M
1W Performance:
-14.71%
1M Performance:
-27.78%
6M Performance:
-35.11%
1Y Performance:
-9.94%
1-Day Range:
Value
$0.82
$0.9799
1-Week Range:
Value
$0.79
$1.04
52-Week Range:
Value
$0.7327
$2.098

Io Biotech Inc Stock (IOBT) Company Profile

Name
Name
Io Biotech Inc
Name
Phone
(457) 070-2980
Name
Address
OLE MAALOES VEH 3, COPENHAGEN
Name
Employee
68
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
IOBT's Discussions on Twitter

Compare IOBT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
IOBT 0.8999 58.37M 0 -86.08M -72.06M -2.57
VRTX 467.50 119.83B 10.63B -479.80M -1.35B 13.33
REGN 761.42 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 564.61 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.62 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.64 24.08B 3.30B -501.07M 1.03B 11.54

Io Biotech Inc Stock (IOBT) Latest News

pulisher
Nov 15, 2024

HC Wainwright Decreases Earnings Estimates for IO Biotech - MarketBeat

Nov 15, 2024
pulisher
Nov 13, 2024

Neuronetics (NASDAQ: STIM) Announces Key Financial Updates and FDA Clearance for Adolescent Treatment - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

IO Biotech (NASDAQ:IOBT) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

IO Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

IO Biotech Reports Advancing Cancer Trials Despite Widening Q3 Losses; Cash Position at $80.2M | IOBT Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

IO Biotech Announces Participation in Upcoming Investor Conferences - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

IO Biotech to Present at Jefferies, Piper Sandler Healthcare Conferences | IOBT Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 10, 2024

Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com

Nov 10, 2024
pulisher
Nov 08, 2024

IO Biotech, Inc. Announces Data from the NSCLC Cohort in the Phase 2 Basket Trial of IO102-IO103 - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Promising results for IO Biotech’s cancer vaccine By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study - ForexTV.com

Nov 07, 2024
pulisher
Nov 07, 2024

IO Biotech's Cancer Vaccine Shows 81% Disease Control Rate in Lung Cancer Trial | IOBT Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 03, 2024

Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation - Yahoo Finance

Nov 03, 2024
pulisher
Oct 30, 2024

Legend Biotech Chooses Philadelphia for New R&D Center - BioBuzz

Oct 30, 2024
pulisher
Oct 29, 2024

Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7% - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Melanoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 28, 2024
pulisher
Oct 27, 2024

IO Biotech, Inc. (NASDAQ:IOBT) Shares Sold by Novo Holdings A S - MarketBeat

Oct 27, 2024
pulisher
Oct 23, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 23, 2024

Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable - GlobeNewswire

Oct 23, 2024
pulisher
Oct 17, 2024

Melanoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR

Oct 17, 2024
pulisher
Oct 17, 2024

Melanoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA, Companies by DelveInsight - Barchart

Oct 17, 2024
pulisher
Oct 13, 2024

38,076 Shares in Montauk Renewables, Inc. (NASDAQ:MNTK) Bought by Squarepoint Ops LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Bank of America Boosts Voya Financial (NYSE:VOYA) Price Target to $88.00 - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Update - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Norstella introduces a fully integrated data asset for biopharma - European Pharmaceutical Manufacturer

Oct 11, 2024
pulisher
Oct 11, 2024

Immuno-Oncology Clinical Trials Market Valuation to Reach $18.1 Billion By 2032 - 대구포스트

Oct 11, 2024
pulisher
Oct 05, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - ForexTV.com

Oct 05, 2024
pulisher
Oct 04, 2024

VerImmune Secures $4.5 Million to Drive Biotech Innovation - BioBuzz

Oct 04, 2024
pulisher
Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

ARHT Media Inc. Announces Filing for Bankruptcy - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's 39th Annual Meeting - Marketscreener.com

Oct 04, 2024
pulisher
Oct 03, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Oct 03, 2024
pulisher
Oct 01, 2024

5 Best Stem Cell Companies to Invest In (November 2024) - Securities.io

Oct 01, 2024
pulisher
Sep 30, 2024

ProShare Advisors LLC Sells 113 Shares of Reinsurance Group of America, Incorporated (NYSE:RGA) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Novo Holdings A S Sells 658,809 Shares of IO Biotech, Inc. (NASDAQ:IOBT) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

American Century Companies Inc. Purchases 75,475 Shares of Lifetime Brands, Inc. (NASDAQ:LCUT) - Defense World

Sep 30, 2024
pulisher
Sep 27, 2024

PCI Pharma Services invests over $365 million in EU and US facilities - European Pharmaceutical Manufacturer

Sep 27, 2024
pulisher
Sep 26, 2024

Sei Investments Co. Buys 24,363 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Cancer Vaccines Market Detailed In Recent Development to Grow - openPR

Sep 26, 2024
pulisher
Sep 23, 2024

Up 41% YTD, This Standout Growth Stock Has More Upside Ahead - The Globe and Mail

Sep 23, 2024
pulisher
Sep 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Sep 20, 2024
pulisher
Sep 18, 2024

Investors in cash trouble should check out IO Biotech Inc (IOBT) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 18, 2024
pulisher
Sep 18, 2024

IO Biotech (NASDAQ:IOBT) Rating Reiterated by HC Wainwright - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

IO Biotech (NASDAQ:IOBT) PT Raised to $6.00 - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

IO Biotech Inc [IOBT] moved up 3.22: Why It’s Important - The DBT News

Sep 17, 2024
pulisher
Sep 17, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Sep 17, 2024
pulisher
Sep 17, 2024

Piper Sandler maintains Overweight rating on IO Biotech shares By Investing.com - Investing.com Canada

Sep 17, 2024

Io Biotech Inc Stock (IOBT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Io Biotech Inc Stock (IOBT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Novo Holdings A/S
10% Owner
Jul 25 '24
Sale
1.33
51,522
68,339
4,377,927
Novo Holdings A/S
10% Owner
Jul 26 '24
Sale
1.31
23,478
30,787
4,354,449
Novo Holdings A/S
10% Owner
May 10 '24
Sale
1.22
658,809
802,495
4,429,449
Novo Holdings A/S
10% Owner
Feb 09 '24
Sale
1.50
658,809
988,411
5,088,258
Burkavage Brian
Chief Accounting Officer
Nov 22 '23
Buy
1.03
5,000
5,175
11,500
Burkavage Brian
Chief Accounting Officer
Nov 21 '23
Buy
0.99
5,000
4,950
6,500
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):